BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15829421)

  • 1. Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells.
    Zhang C; Zhang J; Sun R; Feng J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jun; 5(6):1057-67. PubMed ID: 15829421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The negative regulatory effect of IFN-gamma on cognitive function of human natural killer cells].
    Zhang C; Tian ZG; Zhang J; Feng JB; Zhang JH; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):324-7. PubMed ID: 15312339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C; Zhang J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
    Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA
    J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of human natural killer cell receptors in early life.
    Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
    Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
    Romero AI; Thorén FB; Brune M; Hellstrand K
    Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
    Graham CM; Christensen JR; Thomas DB
    Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C.
    Houchins JP; Lanier LL; Niemi EC; Phillips JH; Ryan JC
    J Immunol; 1997 Apr; 158(8):3603-9. PubMed ID: 9103421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
    Zhang C; Zhang J; Niu J; Zhang J; Tian Z
    Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
    Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
    Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
    J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation.
    Romero P; Ortega C; Palma A; Molina IJ; Peña J; Santamaría M
    J Leukoc Biol; 2001 Aug; 70(2):219-24. PubMed ID: 11493613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
    Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
    Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
    Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
    Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.